Japan’s SBI Pharmaceutical Plans Bahraini Plant, Alwasat Reports

SBI Pharmaceuticals Co., a Japanese drug maker, plans to open a plant in Bahrain, Alwasat reported, citing a statement from Bahrain’s Ministry of Trade.

Japan’s Cosmo Oil Co. owns 14.4 percent of SBI Pharmaceuticals.

To contact the reporter on this story: Wael Mahdi in Manama, Bahrain at wmahdi@bloomberg.net

To contact the editor responsible for this story: Andrew J. Barden at barden@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.